Smoking Status and Serum NSE Level, as Prognostic Factors in Adenocarcinoma of Lung.
10.4046/trd.2005.58.6.582
- Author:
Hee Kyoo KIM
1
;
Chul Ho OK
;
Mann Hong JUNG
;
Tae Won JANG
Author Information
1. Department of Internal Medicine, College of Medicine, Kosin University College of Medicine, Busan, Korea. jangtw@ns.kosinmed.or.kr
- Publication Type:Original Article
- Keywords:
Adenocarcinoma of lung;
survival time;
smoking;
serum NSE
- MeSH:
Adenocarcinoma*;
Carcinoembryonic Antigen;
Female;
Humans;
Incidence;
Lung*;
Male;
Multivariate Analysis;
Phosphopyruvate Hydratase;
Prognosis;
Reference Values;
Retrospective Studies;
Smoke*;
Smoking*;
Biomarkers, Tumor;
Weight Loss
- From:Tuberculosis and Respiratory Diseases
2005;58(6):582-589
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The incidence of lung adenocarcinoma, which is more prevalent in women and nonsmokers, is increasing. The aim of this study was to determine the prognostic factors of an adenocarcinoma of the lung. MATERIAL AND METHOD: The clinical information of patients diagnosed with an adenocarcinoma of the lung at the Kosin University Gospel Hospital from January 1994 to July 2004 was reviewed retrospectively. The survival time of these patients was analyzed by the patient's age, gender, performance status, weight loss, smoking history, location of the primary tumor, clinical stage, serologic tumor markers, and treatment modality. RESULTS: For all 422 patients with an adenocarcinoma of the lung, 247 (58.5%) were male, and their mean age was 59.8 years the. The majority of patients were smokers (58.3%), and the tumors were located in the periphery (59.7%). In the smokers, the tumor was located more in the central airway compared to the non-smokers (42.8% vs. 31.9%, p=0.12). The overall median survival time was 390 days (95% CI;304-436 days). Univariate survival analysis revealed that an older age (>or=65 years old), male, weight loss, smoker, central type, advanced clinical stage, elevated serum carcinoembryonic antigen (CEA, >5 ng/ml) and neuron specific enolase (NSE, >15 ng/ml), and the supportive care only were significantly poor prognostic factors. The median survival time was shorter in the smokers than nonsmokers (289 days vs. 533 days, p<0.001). In addition, it was also shorter in the elevated NSE group than in the normal range group (207 days vs. 469 days, p<0.001). Multivariate analysis showed that age, clinical stage, serum NSE, smoking status, and treatment modality were independent predictors of survival (hazard ratios: 1.68, 1.94, 1.92, 2.39 and 1.57, respectively). CONCLUSIONS: Smoking is an important prognostic factor in an adenocarcinoma of the lung, but not gender. This suggests that the better prognosis of women is more related with the lower rate of smoking. In addition, the elevated serum NSE is also an important prognostic in an adenocarcinoma of the lung.
